An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo - PubMed (original) (raw)
. 1996 Dec 5;13(11):2387-96.
R H Xiang, D K Garcia, K E Kerbacher, S L Moore, C H Hensel, P Liu, M J Siciliano, K Kok, A van den Berg, P Veldhuis, C H Buys, A M Killary, S L Naylor
Affiliations
- PMID: 8957080
An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo
M C Todd et al. Oncogene. 1996.
Abstract
High frequencies of allelic loss on the short arm of chromosome 3 in small cell lung cancer (SCLC) and a number of other tumors suggest the existence of a tumor suppressor gene(s) within the deleted regions. Two small cell lung cancer lines, NCI H740 and GLC20, have been described which have homozygous deletions in the region 3p21.3. The deleted region overlaps with a 2 Mb fragment of human DNA present in the interspecies hybrid HA(3)BB9F, that suppresses tumor formation by mouse A9 fibrosarcoma cells. Human sequences from this cell hybrid were isolated using inter Alu PCR. From this starting point, a P1 contig was developed for the region of 450 Kb that is common to the homozygous deletions seen in the SCLC lines NCI H740 and GLC20 and is also present in HA(3)BB9F, the suppressed A9 hybrid. Individual P1 clones were assayed for their ability to suppress the tumorigenicity of the mouse fibrosarcoma cell line A9 as assayed by injection of transfected A9 cells into athymic nude mice. The introduction of one of the P1 clones into A9 cells resulted in suppression of tumor growth whereas two other P1 clones from the contig failed to suppress tumor formation in athymic nude mice. These data functionally delimit a tumor suppressor locus to a region of 80 kb within a P1 clone at 3p21.3.
Similar articles
- A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL. Daly MC, et al. Oncogene. 1993 Jul;8(7):1721-9. Oncogene. 1993. PMID: 8390035 - Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice.
Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL. Xiang R, et al. Cancer Res. 2002 May 1;62(9):2637-43. Cancer Res. 2002. PMID: 11980661 - Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW. Wiest JS, et al. J Cell Biochem Suppl. 1997;28-29:64-73. J Cell Biochem Suppl. 1997. PMID: 9589350 Review. - Cancer related genes in small cell lung cancer.
Rygaard K. Rygaard K. APMIS Suppl. 1994;44:1-39. APMIS Suppl. 1994. PMID: 7917497 Review. No abstract available.
Cited by
- ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women.
Kinney N, Varghese RT, Anandakrishnan R, Garner HRS. Kinney N, et al. Cancer Inform. 2017 Dec 13;16:1176935117746644. doi: 10.1177/1176935117746644. eCollection 2017. Cancer Inform. 2017. PMID: 29276372 Free PMC article. - Deficiency of a potential 3p21.3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice.
Yin X, Cong X, Yan M, Zhang DE. Yin X, et al. Lung Cancer. 2009 Feb;63(2):194-200. doi: 10.1016/j.lungcan.2008.05.009. Epub 2008 Jun 24. Lung Cancer. 2009. PMID: 18571763 Free PMC article. - Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF, Minna JD. Tomizawa Y, et al. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13954-9. doi: 10.1073/pnas.231490898. Proc Natl Acad Sci U S A. 2001. PMID: 11717452 Free PMC article. - Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.
Kusy S, Nasarre P, Chan D, Potiron V, Meyronet D, Gemmill RM, Constantin B, Drabkin HA, Roche J. Kusy S, et al. Neoplasia. 2005 May;7(5):457-65. doi: 10.1593/neo.04721. Neoplasia. 2005. PMID: 15967098 Free PMC article. - Semaphorins and their receptors in lung cancer.
Potiron VA, Roche J, Drabkin HA. Potiron VA, et al. Cancer Lett. 2009 Jan 8;273(1):1-14. doi: 10.1016/j.canlet.2008.05.032. Epub 2008 Jul 14. Cancer Lett. 2009. PMID: 18625544 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous